Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity available at the Rutherford Cancer Centre North West in Liverpool from late 2020.
Dr Esme Hill graduated from Birmingham University, also completing an Intercalated BSc in the History of Medicine at University College London before training as physician in the West Midlands. Dr Hill decided to specialise in Oncology and completed her training at the Royal Free Hospital and then as a Specialist Registrar in Clinical Oncology on the Oxford Clinical Oncology training scheme.
Dr Hill has extensive experience in the management of acutely unwell cancer patients, with a weekly session dedicated to “Acute Oncology”. Dr Hill is the malignant spinal cord compression clinical lead at the Royal Berkshire Hospital in Reading as well as an Educational Supervisor to Core Medical trainees.
She's a core member of the Upper Gastrointestinal Cancer Multi-Disciplinary Teams and Cancer of Unknown Primary Multi-Disciplinary Teams at both the Royal Berkshire Hospital, Reading and Wexham Park Hospital, Slough. She attends the Oxford Oesophago-gastric and Hepato-biliary Multi-Disciplinary Team meetings on a weekly basis via video-conference and has a strong working relationship with the Oxford teams.
Upper Gastrointestinal Cancer Multi-Disciplinary Team (Royal Berkshire Hospital, Reading and Wexham Park Hospital)
Cancer of Unknown Primary Multi-Disciplinary Team (Royal Berkshire Hospital, Reading and Wexham Park Hospital)
Dr Esme Hill does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Esme Hill does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Esme Hill does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or